Dudediligence.

60 Degrees Pharmaceuticals, Inc

SXTPNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$135,293Sep ’24$241,635Dec ’24$163,552Mar ’25$100,932Jun ’25$437,602Sep ’25$303,385Dec ’25$162,092Mar ’26$207,898Jun ’26
Net income, by quarter
−$2.2MSep ’24−$2.0MDec ’24−$1.9MMar ’25−$1.7MJun ’25−$2.3MSep ’25−$1.4MDec ’25−$2.1MMar ’26−$2.3MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$223,208$253,573$607,574$1.0M
Gross profitnone on file−$209,162−$220,977$222,809$223,776
Operating incomenone on file−$1.8M−$5.2M−$9.7M−$7.8M
Net incomenone on file−$6.2M−$3.8M−$7.9M−$7.4M
Operating cash flownone on file−$1.0M−$4.5M−$5.6M−$6.8M
Free cash flownone on filenone on file−$4.6M−$5.8M−$7.0M
Cash$115,399$264,865$2.1M$1.7M$1.5M
Debtnone on filenone on file$8,772$155,891$152,775
Shares outstandingnone on file2.4M96.8K141.7K1.2M